IAVI and Scripps Research Join Efforts with NIH to Expedite Development of Globally Accessible and Affordable HIV Antibody Combination ProductsMay 26, 2020 April 23, 2020 April 22, 2020
Japan's Commitment to Contribute to the World Bank for COVID-19 Vaccine Research Sets Example and Will Advance Global Health, IAVI SaysApril 1, 2020
More COVID-19 News
Thumbi Ndung'u, Ph.D., provides a view of current strategies for HIV vaccine and cure design
June 15, 2020
Powerful antibodies isolated from recovered donors protect against COVID-19 disease in an animal model
Findings offer promise for accelerated development of antibody-based prevention and treatment for COVID-19
June 5, 2020
Summarizing the impact of COVID-19 on ongoing HIV and TB prevention research
June 3, 2020
Mark Feinberg and Swati Gupta introduce viewers to the COVID-19 vaccine candidate, which uses the same technology as Merck’s Ebola vaccine.
May 27, 2020
Seventh edition of webinar series tackles community engagement in a time of social distancing.
May 26, 2020
New collaboration to leverage complementary expertise and capabilities with rVSV technology to advance novel vaccine candidate
April 23, 2020
Japan's commitment to contribute to the World Bank for COVID-19 vaccine research sets example and will advance global health, IAVI says (in Japanese).
April 22, 2020
Japan's Commitment to Contribute to the World Bank for COVID-19 Vaccine Research Sets Example and Will Advance Global Health, IAVI Says
Government of Japan, in partnership with the World Bank, commits funds to COVID-19 vaccine development.
March 30, 2020
IAVI's response to the COVID-19 pandemic